Trading Report: The UBS Asset Management Americas Inc. invests in Orthofix International NV (OFIX) Shares

The UBS Asset Management Americas Inc. invests in Orthofix International NV (OFIX) Shares

UBS Asset Management Americas Inc. raised its stake in shares of Orthofix International NV (NASDAQ:OFIX) by 15.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,511 shares of the medical device company’s stock after buying an additional 1,400 shares during the period. UBS Asset Management Americas Inc. owned 0.06% of Orthofix International NV worth $446,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. TIAA CREF Investment Management LLC raised its stake in shares of Orthofix International NV by 4.7% in the first quarter. TIAA CREF Investment Management LLC now owns 95,843 shares of the medical device company’s stock valued at $3,979,000 after buying an additional 4,269 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in shares of Orthofix International NV by 59.7% in the first quarter. Goldman Sachs Group Inc. now owns 65,550 shares of the medical device company’s stock valued at $2,721,000 after buying an additional 24,513 shares during the last quarter. Bogle Investment Management L P DE raised its stake in shares of Orthofix International NV by 37.6% in the first quarter. Bogle Investment Management L P DE now owns 81,833 shares of the medical device company’s stock valued at $3,397,000 after buying an additional 22,365 shares during the last quarter. Renaissance Technologies LLC raised its stake in shares of Orthofix International NV by 78.7% in the first quarter. Renaissance Technologies LLC now owns 456,379 shares of the medical device company’s stock valued at $18,949,000 after buying an additional 201,020 shares during the last quarter. Finally, Acadian Asset Management LLC raised its stake in shares of Orthofix International NV by 25.1% in the second quarter. Acadian Asset Management LLC now owns 660,196 shares of the medical device company’s stock valued at $27,993,000 after buying an additional 132,537 shares during the last quarter. 91.29% of the stock is currently owned by institutional investors.

Orthofix International NV (NASDAQ:OFIX) opened at 38.25 on Friday. The stock’s market cap is $693.24 million. Orthofix International NV has a 52-week low of $33.74 and a 52-week high of $48.25. The stock has a 50 day moving average price of $41.48 and a 200 day moving average price of $43.58.

OFIX has been the topic of several research analyst reports. Zacks Investment Research lowered Orthofix International NV from a “buy” rating to a “hold” rating in a report on Tuesday, July 5th. TheStreet downgraded Orthofix International NV from a “buy” rating to a “hold” rating in a research report on Wednesday, August 3rd.

In other news, insider Michael Finegan sold 25,000 shares of the business’s stock in a transaction dated Thursday, September 1st. The stock was sold at an average price of $45.16, for a total value of $1,129,000.00. Following the completion of the sale, the insider now directly owns 51,670 shares of the company’s stock, valued at approximately $2,333,417.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 5.10% of the stock is owned by insiders.

About Orthofix International NV

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Related posts

Leave a Comment